AEON Biopharma, Inc.
AEON
$0.69
-$0.0043-0.62%
AMEX
06/30/2025 | 03/31/2025 | ||||
---|---|---|---|---|---|
Revenue | -- | -- | |||
Total Other Revenue | -- | -- | |||
Total Revenue | -- | -- | |||
Cost of Revenue | -- | -- | |||
Gross Profit | -- | -- | |||
SG&A Expenses | 4.26% | 18.87% | |||
Depreciation & Amortization | -- | -- | |||
Other Operating Expenses | -- | -- | |||
Total Operating Expenses | 9.42% | -30.29% | |||
Operating Income | -9.42% | 30.29% | |||
Income Before Tax | -173.03% | 336.84% | |||
Income Tax Expenses | -- | -- | |||
Earnings from Continuing Operations | -173.03% | 336.84% | |||
Earnings from Discontinued Operations | -- | -- | |||
Extraordinary Item & Accounting Change | -- | -- | |||
Minority Interest in Earnings | -- | -- | |||
Net Income | -173.03% | 336.84% | |||
EBIT | -9.42% | 30.29% | |||
EBITDA | -9.44% | 30.34% | |||
EPS Basic | -126.29% | -39.24% | |||
Normalized Basic EPS | -123.73% | 121.22% | |||
EPS Diluted | -126.29% | -34.13% | |||
Normalized Diluted EPS | -123.73% | 121.26% | |||
Average Basic Shares Outstanding | 177.80% | 618.91% | |||
Average Diluted Shares Outstanding | 177.80% | 617.61% | |||
Dividend Per Share | -- | -- | |||
Payout Ratio | -- | -- |